Share This Page
Drug Price Trends for HM STOOL SOFTENER
✉ Email this page to a colleague
Average Pharmacy Cost for HM STOOL SOFTENER
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HM STOOL SOFTENER 250 MG SFTGL | 62011-0474-01 | 0.05106 | EACH | 2025-03-19 |
| HM STOOL SOFTENER 100 MG SFTGL | 62011-0421-01 | 0.02743 | EACH | 2025-03-19 |
| HM STOOL SOFTENER 100 MG SFTGL | 62011-0421-02 | 0.02743 | EACH | 2025-03-19 |
| HM STOOL SOFTENER 250 MG SFTGL | 62011-0474-01 | 0.05011 | EACH | 2025-02-19 |
| HM STOOL SOFTENER 100 MG SFTGL | 62011-0421-01 | 0.02705 | EACH | 2025-02-19 |
| HM STOOL SOFTENER 100 MG SFTGL | 62011-0421-02 | 0.02705 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Stool Softener Market Analysis and Price Projections: A Comprehensive Overview
Market Size and Growth
The global stool softener market has been experiencing robust growth, driven by several key factors. As of 2023, the market size was valued at $1.58 billion and is projected to grow to $1.69 billion in 2024, with a compound annual growth rate (CAGR) of 7.4%[1].
By 2028, the market is expected to reach $2.26 billion, maintaining a CAGR of 7.5%. This growth is attributed to increasing cases of gastrointestinal conditions, higher healthcare spending, and the shift of many stool softeners from prescription-only to over-the-counter status[1].
Drivers of the Market
Several factors are driving the growth of the stool softener market:
- Aging Population: The increasing geriatric population suffering from constipation is a significant driver. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 33 in 100 adults above the age of 60 suffer from constipation[4].
- Dietary Changes and Sedentary Lifestyle: Changes in diet and the adoption of sedentary lifestyles have led to an increase in constipation cases, thereby driving the demand for stool softeners[4][5].
- Increased Public Awareness: Greater awareness about digestive health has prompted more people to seek medical help and use stool softeners[1].
- Higher Healthcare Spending: Increased spending on healthcare, including the development and approval of more effective stool softener formulations, is also a key driver[1].
Market Segmentation
The stool softener market is segmented in various ways to understand its dynamics better:
By Type
- Liquid: Liquid formulations are popular due to their ease of use and quick action.
- Softgel Capsule: Softgel capsules, such as HM STOOL SOFT SFTGEL 100MG, are also widely used for their convenience and effectiveness[2].
By Form
- Medicines: This includes various types of medications like osmotic laxatives, bulk-forming agents, and stimulants.
- Procedures: This segment includes enemas and suppositories[4].
By Mode of Administration
- Oral: Oral medications, such as drugs, capsules, and powdered formulations, dominate the market due to their non-invasive nature and ease of use.
- Rectal: Rectal administration, including enemas and suppositories, is also significant but less preferred compared to oral methods[4].
By Availability
- Over-The-Counter (OTC): The shift of many stool softeners from prescription-only to OTC status has significantly boosted market growth.
- Prescription: Prescription medications, such as lubiprostone and linaclotide, are also crucial, especially for severe cases of constipation[1][4].
By End Use
- Hospitals: Hospitals use stool softeners for patients undergoing surgical procedures or suffering from severe constipation.
- Clinics: Clinics also prescribe stool softeners for outpatient treatments.
- Home Care: The home care segment has seen significant growth as patients prefer treating constipation in the comfort of their homes[4][5].
Regional Analysis
The market is geographically segmented into several regions:
- North America: This region is expected to register rapid revenue growth due to the increasing prevalence of constipation in the pediatric population and the presence of major pharmaceutical companies[5].
- Asia Pacific: The Asia Pacific region is predicted to witness rapid growth due to the increasing prevalence of constipation and growing awareness of digestive health[3].
- Europe: Europe is expected to see steady growth driven by the rising incidence of Chronic Idiopathic Constipation (CIC) and other bowel disorders[5].
Price Projections for HM STOOL SOFTENER
Given the market trends and growth projections, here are some insights into the pricing of HM STOOL SOFTENER:
- Current Pricing: HM STOOL SOFT SFTGEL 100MG is currently priced around $7.99 for a pack of 100 softgels[2].
- Market Trends: The overall market is expected to grow, driven by increasing demand and higher healthcare spending. This could lead to stable or slightly increasing prices for stool softeners, including HM STOOL SOFT SFTGEL.
- Competitive Landscape: The market is fairly fragmented with many large and medium-sized companies. Competitive pricing strategies, mergers, and acquisitions could influence the pricing of specific products like HM STOOL SOFT SFTGEL[5].
Key Takeaways
- The global stool softener market is growing rapidly, driven by an aging population, dietary changes, and increased healthcare spending.
- The market is segmented by type, form, mode of administration, availability, and end use, with oral medications and home care segments being particularly significant.
- Regional growth varies, with North America and Asia Pacific expected to see rapid growth.
- The pricing of HM STOOL SOFT SFTGEL is likely to remain stable or increase slightly due to market growth and competitive dynamics.
FAQs
What are the main drivers of the stool softener market?
The main drivers include an aging population, dietary changes, increased public awareness about digestive health, higher healthcare spending, and the shift of many stool softeners from prescription-only to over-the-counter status[1][4].
Which segment dominates the stool softener market by mode of administration?
The oral segment dominates the market due to the ease of use and non-invasive nature of oral medications[4].
What is the projected CAGR for the stool softener market from 2023 to 2028?
The market is expected to grow at a CAGR of 7.5% from 2023 to 2028[1].
Which region is expected to see rapid revenue growth in the stool softener market?
North America is expected to register rapid revenue growth due to the increasing prevalence of constipation in the pediatric population and the presence of major pharmaceutical companies[5].
What are some of the key companies operating in the stool softener market?
Key companies include F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., AstraZeneca, GlaxoSmithKline plc, and Johnson & Johnson Private Limited, among others[3][5].
Sources
- The Business Research Company: Stool Softener Global Market Report 2024
- Tristate RX: HM STOOL SOFT SFTGEL 100MG 100
- Global Market Estimates: Constipation Laxative Market Analysis | Size & Forecasts
- Emergen Research: Stool Softener Market Forecast Report | Statistics, Revenue, Demand and Trend Analysis Research Report by 2030
- Emergen Research: Stool Softener Industry Trend, Forecast [2021-2030] | Market Report
More… ↓
